Achillion Pharmaceuticals has announced the addition of two members to the senior management team, including the appointment of a new general counsel and secretary, and a new senior vice president of regulatory affairs.
Martha Manning joined Achillion in February as general counsel. Previously, she held the same role from 2013 to 2016 at iCeutica, a drug development company. Prior to that, she served as chief legal officer of OraPharma, a J&J spinout company, from 2011 to 2012, when the company was acquired by Valeant. She joined OraPharma from Sandoz, the generic pharmaceutical division of Novartis, where she served as general counsel from 2008 to 2011.
